Sunday, July 26, 2026

Dow Jones, S&P 500, Nasdaq futures fall as US-Iran tensions escalate

Date:

US Stock Market Update: US stock futures slipped on Monday as a fresh flare-up in US-Iran tensions over the weekend rattled investor sentiment and cast a shadow over fragile peace efforts. Dow Jones Industrial Average futures fell 258 points (0.5%), while S&P 500 and Nasdaq-100 futures declined 0.5% and 0.4%, respectively.

US stock futures slipped on Monday as a fresh flare-up in US-Iran tensions over the weekend rattled investor sentiment and cast a shadow over fragile peace efforts. Dow Jones Industrial Average futures fell 258 points (0.5%), while S&P 500 and Nasdaq-100 futures declined 0.5% and 0.4%, respectively.

The downturn comes after US President Donald Trump claimed that American forces fired on and seized an Iranian-flagged cargo ship in the Gulf of Oman, escalating the conflict after Tehran skipped another round of US-led peace talks. The situation worsened as Iran moved to restrict vessel traffic through the Strait of Hormuz, stoking fears of supply disruptions in a key global oil route.

Crude prices surged on the back of these developments, with West Texas Intermediate jumping over 6% to above $88 per barrel and Brent crude climbing past $95 per barrel, amplifying inflation concerns and adding another layer of uncertainty for markets already navigating record highs.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Blinkit is now nearly as large as Zepto and Instamart combined

Eternal has said in its June-quarter shareholder letter that...

Wall St Week Ahead-US stocks face tests from Fed decision, tech-led earnings deluge

(दोहराया गया अनुसूचित कॉलम मूल रूप से 24 जुलाई...

US judge approves Anthropic’s $1.5 billion AI copyright settlement, largest in US history

A federal judge in San Francisco on Monday signed...

Zydus receives USFDA approval to begin Phase III trial of sickle cell anaemia treatement drug with ICMR

Zydus Lifesciences on Thursday, July 23, said it has...